ロード中...
Targeting neoantigens for cancer immunotherapy
Neoantigens, a type of tumor-specific antigens derived from non-synonymous mutations, have recently been characterized as attractive targets for cancer immunotherapy. Owing to the development of next-generation sequencing and utilization of machine-learning algorithms, it has become feasible to comp...
保存先:
| 出版年: | Biomark Res |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8317330/ https://ncbi.nlm.nih.gov/pubmed/34321091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00315-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|